PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Affiliations

• ¹ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
• ² PET Committee of the German Society of Nuclear Medicine, Marburg, Germany.
• ³ Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
• ⁴ Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
• ⁵ Institute of Nuclear Medicine, UCLH NHS Foundation Trust, London, UK.
• ⁶ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
• ⁷ Division of Nuclear Medicine and Theranostics, IEO European Institute of Oncology, IRCCS, Milan, Italy.
• ⁸ Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
• ⁹ Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
• ¹⁰ IRCCS, AOU Bologna, Bologna, Italy.
• ¹¹ Department of Nuclear Medicine, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-University and Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
• ¹² Department of Nuclear Medicine, Division of Nuclear Medicine and Molecular Imaging, University Hospital Leuven, KU Leuven, Louvain, Belgium.
• ¹³ Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
• ¹⁴ Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, USA.
• ¹⁵ Banner MD Anderson Cancer Center, Phoenix, AZ, USA.
• ¹⁶ Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
• ¹⁷ School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, Dresden, Germany.
• ¹⁸ German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.
• ¹⁹ Department of Nuclear Medicine, University Medical Center, University of Rostock, Rostock, Germany.
• ²⁰ Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
• ²¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA.
• ²² Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
• ²³ Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
• ²⁴ Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
• ²⁵ Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, NY, USA.
• ²⁶ Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, University of Michigan, Ann Arbor, MI, USA.
• ²⁷ Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ²⁸ Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• ²⁹ Pharmaceutical Radiochemistry, Technische Universität München, Walther-Meißner-Str. 3, 85748, Garching, Germany.
• ³⁰ Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
• ³¹ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. ken.herrmann@uk-essen.de.